• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在模块化实验室-Eazy模块上全自动合成镥标记的FAPI衍生物。

Fully-automated synthesis of Lu labelled FAPI derivatives on the module modular lab-Eazy.

作者信息

Eryilmaz Kurtulus, Kilbas Benan

机构信息

Moltek A. S. Gebze Organize Sanayi, 41400 Gebze, Kocaeli, Turkey.

出版信息

EJNMMI Radiopharm Chem. 2021 Apr 16;6(1):16. doi: 10.1186/s41181-021-00130-3.

DOI:10.1186/s41181-021-00130-3
PMID:33864154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8052395/
Abstract

BACKGROUND

To the best of our knowledge, manually production of [Lu]Lu-FAPI radiopharmaceutical derivatives has been only described in literature. In this work, a fully-automated [Lu]Lu-FAPI synthesis has been well designed for the first time using commercially available synthesis module. In addition to the development of an automated system with disposable cassette, quality control (QC) and stability studies were comprehensively presented.

RESULTS

A fully automated synthesis of [Lu]Lu-FAPI derivatives was achieved on the Modular Lab Eazy (ML Eazy) with high radiochemical yield ([Lu]Lu-FAPI-04; 88% ± 3, [Lu]Lu-FAPI-46; 86% ± 3). Chromatographic analysis indicated the formation of radiosynthesis with an absolute radiochemical purity (99%). Stability experiments clarified the durability of the products within 4 days. All obtained specifications are consistent to European Pharmacopoeia.

CONCLUSION

A fully automated synthesis of [Lu]Lu-FAPI radiopharmaceuticals was accomplished regarding quality control standards and quality assurance by using commercially available a modular approach namely ML Eazy with disposable customized cassette and template.

摘要

背景

据我们所知,文献中仅描述了[镥]镥-FAPI放射性药物衍生物的手工生产。在本研究中,首次使用市售合成模块精心设计了一种全自动的[镥]镥-FAPI合成方法。除了开发带有一次性盒的自动化系统外,还全面介绍了质量控制(QC)和稳定性研究。

结果

在模块化实验室Eazy(ML Eazy)上实现了[镥]镥-FAPI衍生物的全自动合成,放射性化学产率较高([镥]镥-FAPI-04;88%±3,[镥]镥-FAPI-46;86%±3)。色谱分析表明放射性合成产物的绝对放射性化学纯度为99%。稳定性实验明确了产品在4天内的耐久性。所有获得的规格均符合欧洲药典。

结论

通过使用市售的模块化方法,即带有一次性定制盒和模板的ML Eazy,在质量控制标准和质量保证方面完成了[镥]镥-FAPI放射性药物的全自动合成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/4107adef35be/41181_2021_130_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/ab29a7038098/41181_2021_130_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/c200a0b822f1/41181_2021_130_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/33c2551ccd04/41181_2021_130_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/955061d927e0/41181_2021_130_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/04a8e2ed44e7/41181_2021_130_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/c24bd8c20850/41181_2021_130_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/ebcb7f417f0d/41181_2021_130_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/4107adef35be/41181_2021_130_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/ab29a7038098/41181_2021_130_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/c200a0b822f1/41181_2021_130_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/33c2551ccd04/41181_2021_130_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/955061d927e0/41181_2021_130_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/04a8e2ed44e7/41181_2021_130_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/c24bd8c20850/41181_2021_130_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/ebcb7f417f0d/41181_2021_130_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbfb/8052395/4107adef35be/41181_2021_130_Fig8_HTML.jpg

相似文献

1
Fully-automated synthesis of Lu labelled FAPI derivatives on the module modular lab-Eazy.在模块化实验室-Eazy模块上全自动合成镥标记的FAPI衍生物。
EJNMMI Radiopharm Chem. 2021 Apr 16;6(1):16. doi: 10.1186/s41181-021-00130-3.
2
Fully-automated production of [Ga]Ga-FAPI-46 for clinical application.用于临床应用的[镓]镓-FAPI-46的全自动生产。
EJNMMI Radiopharm Chem. 2020 Dec 17;5(1):31. doi: 10.1186/s41181-020-00112-x.
3
Correction to: Fully-automated synthesis of 177Lu labelled FAPI derivatives on the module modular lab-Eazy.对以下内容的更正:在模块化实验室-Eazy模块上全自动合成177Lu标记的FAPI衍生物。
EJNMMI Radiopharm Chem. 2021 May 19;6(1):17. doi: 10.1186/s41181-021-00134-z.
4
[Ga]/[Y]FAPI-46: Automated production and analytical validation of a theranostic pair.[镓]/[钇]FAPI-46:治疗诊断配对物的自动化生产和分析验证。
Nucl Med Biol. 2022 Jul-Aug;110-111:37-44. doi: 10.1016/j.nucmedbio.2022.04.010. Epub 2022 Apr 30.
5
Automated synthesis of [Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types.在三种常见合成模块和两种发生器类型上,无需对发生器洗脱液进行预纯化即可自动合成[镓]镓-FAPI-46。
EJNMMI Radiopharm Chem. 2022 Jul 29;7(1):20. doi: 10.1186/s41181-022-00172-1.
6
Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of Tb into the Clinic.使用全自动化一次性盒式系统生产 Tb-DOTATOC:将 Tb 引入临床的第一步。
J Nucl Med. 2023 Jul;64(7):1138-1144. doi: 10.2967/jnumed.122.265268. Epub 2023 May 18.
7
Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis.开发并应用一种用于放射性药物合成的全自动多功能盒式模块 Mortenon M1。
Ann Nucl Med. 2024 Apr;38(4):247-263. doi: 10.1007/s12149-023-01893-2. Epub 2023 Dec 25.
8
On the Optimization of the Protocol for Automated Radiosyntheses of [Ga]Ga-Pentixafor, [Ga]Ga-FAPI-4 and [Ga]Ga-DOTATATE in a Modular-Lab Standard.关于在模块化实验室标准下优化[镓]镓-喷替沙氟、[镓]镓-FAPI-4和[镓]镓-奥曲肽自动放射性合成方案的研究
Asia Ocean J Nucl Med Biol. 2024;12(2):149-160. doi: 10.22038/AOJNMB.2024.77059.1545.
9
Microfluidic-based production of [Ga]Ga-FAPI-46 and [Ga]Ga-DOTA-TOC using the cassette-based iMiDEV™ microfluidic radiosynthesizer.使用基于盒式的iMiDEV™微流控放射性合成仪基于微流控技术生产[镓]镓-FAPI-46和[镓]镓-DOTA-TOC 。
EJNMMI Radiopharm Chem. 2023 Dec 13;8(1):42. doi: 10.1186/s41181-023-00229-9.
10
Optimization of Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application.用于临床应用的DOTA-TOC、PSMA-I&T和FAPI-46的镥标记优化
EJNMMI Radiopharm Chem. 2023 May 26;8(1):10. doi: 10.1186/s41181-023-00196-1.

引用本文的文献

1
Improvement of End-of-Synthesis Radiochemical Purity of Lu-DOTA-PSMA-Ligands with Alternative Synthesis Approaches: Conversion Upswing and Side-Products Minimization.采用替代合成方法提高镥-多胺多羧基配体-前列腺特异性膜抗原配体合成终产物的放射化学纯度:转化率上升及副产物最小化
Pharmaceutics. 2024 Nov 30;16(12):1535. doi: 10.3390/pharmaceutics16121535.
2
Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer.用于前列腺癌成像和治疗的前列腺特异性膜抗原靶向 StarPEG 纳米载体。
Adv Healthc Mater. 2024 Jul;13(19):e2304618. doi: 10.1002/adhm.202304618. Epub 2024 May 17.
3
Targeted Alpha Therapy: All We Need to Know about Ac's Physical Characteristics and Production as a Potential Theranostic Radionuclide.

本文引用的文献

1
Fully-automated production of [Ga]Ga-FAPI-46 for clinical application.用于临床应用的[镓]镓-FAPI-46的全自动生产。
EJNMMI Radiopharm Chem. 2020 Dec 17;5(1):31. doi: 10.1186/s41181-020-00112-x.
2
The Latest Developments in Imaging of Fibroblast Activation Protein.成纤维细胞激活蛋白成像的最新进展。
J Nucl Med. 2021 Feb;62(2):160-167. doi: 10.2967/jnumed.120.244806. Epub 2020 Oct 30.
3
A theranostic approach of [Ga]Ga-DOTA.SA.FAPi PET/CT-guided [Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy.
靶向α治疗:关于作为一种潜在的治疗诊断放射性核素的锕的物理特性及生产我们需要了解的一切。
Pharmaceuticals (Basel). 2023 Dec 2;16(12):1679. doi: 10.3390/ph16121679.
4
Fully Automated Production of [Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets.使用回旋加速器液体靶全自动生产 [Ga]GaFAPI-46 及其镓-68 放射性核素
Int J Mol Sci. 2023 Oct 12;24(20):15101. doi: 10.3390/ijms242015101.
5
Optimization of Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application.用于临床应用的DOTA-TOC、PSMA-I&T和FAPI-46的镥标记优化
EJNMMI Radiopharm Chem. 2023 May 26;8(1):10. doi: 10.1186/s41181-023-00196-1.
6
SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis.用Tc-99m标记的HYNIC-FAPI-04进行单光子发射计算机断层显像以延长评估肿瘤纤维化的鉴别时间窗。
Pharmaceuticals (Basel). 2023 Mar 10;16(3):423. doi: 10.3390/ph16030423.
7
Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review.用于乳腺癌的非传统及研究性正电子发射断层显像(PET)放射性示踪剂:一项系统评价
Front Med (Lausanne). 2022 Apr 12;9:881551. doi: 10.3389/fmed.2022.881551. eCollection 2022.
8
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress.基于放射性标记成纤维细胞激活蛋白抑制剂的癌症成像与治疗新前沿:理性回顾与当前进展
Pharmaceuticals (Basel). 2021 Oct 5;14(10):1023. doi: 10.3390/ph14101023.
9
NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images.预测非小细胞肺癌对免疫检查点抑制剂(ICI)免疫治疗反应的生物标志物:从细胞到体内成像
Cancers (Basel). 2021 Sep 10;13(18):4543. doi: 10.3390/cancers13184543.
10
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.编辑委员会对放射化学与放射性药物发展的重点选择。
EJNMMI Radiopharm Chem. 2021 Sep 8;6(1):31. doi: 10.1186/s41181-021-00146-9.
[镓]镓-DOTA.SA.FAPi PET/CT引导下的[镥]镥-DOTA.SA.FAPi放射性核素治疗在一名晚期乳腺癌患者中的诊疗一体化方法:靶向放射性核素治疗的新前沿
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):942-944. doi: 10.1007/s00259-020-04990-w. Epub 2020 Aug 11.
4
Tc-Ga-ICG-Labelled Macroaggregates and Nanocolloids of Human Serum Albumin: Synthesis Procedures of a Trimodal Imaging Agent Using Commercial Kits.Tc-Ga-ICG 标记的人血清白蛋白大颗粒和纳米胶体:使用商业试剂盒合成三模态成像剂的方法。
Contrast Media Mol Imaging. 2020 Jan 22;2020:3629705. doi: 10.1155/2020/3629705. eCollection 2020.
5
Targeting of activated fibroblasts for imaging and therapy.靶向活化成纤维细胞用于成像和治疗。
EJNMMI Radiopharm Chem. 2019 Jul 25;4(1):16. doi: 10.1186/s41181-019-0069-0.
6
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: Cu- and Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.肿瘤基质中成纤维细胞激活蛋白的治疗策略:胰腺癌细胞异种移植鼠模型中的 Cu-和 Ac 标记的 FAPI-04。
J Nucl Med. 2020 Apr;61(4):563-569. doi: 10.2967/jnumed.119.233122. Epub 2019 Oct 4.
7
Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.镓-FAPI PET/CT:28 种不同癌症的示踪剂摄取。
J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.
8
Fibroblast-Activating Protein: Targeting the Roots of the Tumor Microenvironment.成纤维细胞激活蛋白:靶向肿瘤微环境的根源
J Nucl Med. 2018 Sep;59(9):1412-1414. doi: 10.2967/jnumed.118.214361. Epub 2018 Aug 10.
9
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.基于喹啉的治疗性配体的开发用于成纤维细胞激活蛋白的靶向治疗。
J Nucl Med. 2018 Sep;59(9):1415-1422. doi: 10.2967/jnumed.118.210443. Epub 2018 Apr 6.
10
Lutetium PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy.镥-PSMA放射性核素疗法治疗前列腺癌男性患者:当前文献综述及治疗实践方面的讨论
J Med Radiat Sci. 2017 Mar;64(1):52-60. doi: 10.1002/jmrs.227.